Treatment of hepatic amyloid light-chain amyloidosis with bortezomib and dexamethasone in a liver transplant patient

Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment

(2013) Morie A. Gertz   AMERICAN JOURNAL OF HEMATOLOGY

Two cases with hepatic amyloidosis suspected of having primary sclerosing cholangitis

(2013) Kenji Hirano et al.   HEPATOLOGY RESEARCH

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

(2012) Shaji Kumar et al.   JOURNAL OF CLINICAL ONCOLOGY

Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis

(2011) G. Binotto et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management

(2010) Morie A. Gertz   AMERICAN JOURNAL OF HEMATOLOGY

Solid Organ Transplantation in AL Amyloidosis

(2010) P. T. Sattianayagam et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis

(2010) W. Lamm et al.   ANNALS OF HEMATOLOGY

Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features

(2010) S. Kumar et al.   BLOOD

Bortezomib With or Without Dexamethasone in Primary Systemic (Light Chain) Amyloidosis

(2010) Efstathios Kastritis et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score

(2010) Shaji K. Kumar et al.   MAYO CLINIC PROCEEDINGS

Treatment of immunoglobulin light chain amyloidosis

(2009) Morie A. Gertz et al.   Current Hematologic Malignancy Reports